| __timestamp | Verona Pharma plc | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4101058 | 18516000 |
| Thursday, January 1, 2015 | 10763215 | 34140000 |
| Friday, January 1, 2016 | 5579049 | 51872000 |
| Sunday, January 1, 2017 | 32051299 | 71772000 |
| Monday, January 1, 2018 | 24482286 | 97501000 |
| Tuesday, January 1, 2019 | 43892589 | 118590000 |
| Wednesday, January 1, 2020 | 44505000 | 169802000 |
| Friday, January 1, 2021 | 79406000 | 192507000 |
| Saturday, January 1, 2022 | 49283000 | 199563000 |
| Sunday, January 1, 2023 | 17282730 | 253598000 |
Unleashing the power of data
In the ever-evolving landscape of pharmaceutical research, the investment in Research and Development (R&D) is a critical indicator of a company's commitment to innovation. Over the past decade, Verona Pharma plc and Xencor, Inc. have demonstrated contrasting trajectories in their R&D expenditures.
From 2014 to 2023, Xencor, Inc. consistently outpaced Verona Pharma plc, with its R&D spending peaking at approximately 253% higher than Verona's in 2023. This trend highlights Xencor's aggressive pursuit of new therapies, particularly in the field of biopharmaceuticals. Meanwhile, Verona Pharma's R&D investment saw a significant surge in 2021, reaching its zenith, before tapering off in subsequent years.
These financial commitments underscore the strategic priorities of each company, reflecting their respective focuses on innovation and market leadership in the competitive pharmaceutical industry.
R&D Insights: How Eli Lilly and Company and Verona Pharma plc Allocate Funds
AstraZeneca PLC or Xencor, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Gilead Sciences, Inc. and Xencor, Inc.
Comparing Innovation Spending: Bio-Techne Corporation and Xencor, Inc.
Ascendis Pharma A/S vs Verona Pharma plc: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Verona Pharma plc and Catalyst Pharmaceuticals, Inc.
Analyzing R&D Budgets: Verona Pharma plc vs Travere Therapeutics, Inc.
Comparing Innovation Spending: Amneal Pharmaceuticals, Inc. and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Xencor, Inc.
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs Xencor, Inc.
R&D Insights: How PTC Therapeutics, Inc. and Xencor, Inc. Allocate Funds
Analyzing R&D Budgets: Travere Therapeutics, Inc. vs Xencor, Inc.